148 related articles for article (PubMed ID: 12542852)
1. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application.
Caccavo D; Pellegrino NM; Altamura M; Rigon A; Amati L; Amoroso A; Jirillo E
J Endotoxin Res; 2002; 8(6):403-17. PubMed ID: 12542852
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
3. The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function.
Wang ZQ; Xing WM; Fan HH; Wang KS; Zhang HK; Wang QW; Qi J; Yang HM; Yang J; Ren YN; Cui SJ; Zhang X; Liu F; Lin DH; Wang WH; Hoffmann MK; Han ZG
J Immunol; 2009 Nov; 183(10):6646-56. PubMed ID: 19864597
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial mechanisms and potential clinical application of lactoferrin].
Rodríguez-Franco DA; Vázquez-Moreno L; Ramos-Clamont Montfort G
Rev Latinoam Microbiol; 2005; 47(3-4):102-11. PubMed ID: 17061535
[TBL] [Abstract][Full Text] [Related]
5. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
6. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
[TBL] [Abstract][Full Text] [Related]
7. Killing of gram-negative bacteria by lactoferrin and lysozyme.
Ellison RT; Giehl TJ
J Clin Invest; 1991 Oct; 88(4):1080-91. PubMed ID: 1918365
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
10. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
[TBL] [Abstract][Full Text] [Related]
11. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
12. Effects of a bacterial cell wall fragment on monocyte inflammatory function.
Safavi KE; Nichols FC
J Endod; 2000 Mar; 26(3):153-5. PubMed ID: 11199709
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
Andrä J; Gutsmann T; Garidel P; Brandenburg K
J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory role of lactoferrin-lipopolysaccharide interactions.
Puddu P; Latorre D; Valenti P; Gessani S
Biometals; 2010 Jun; 23(3):387-97. PubMed ID: 20191308
[TBL] [Abstract][Full Text] [Related]
16. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
Rubin RM; Noland J; Rosenbaum JT
Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.
Caccavo D; Afeltra A; Pece S; Giuliani G; Freudenberg M; Galanos C; Jirillo E
Infect Immun; 1999 Sep; 67(9):4668-72. PubMed ID: 10456914
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
19. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.
Ruggiero V; Piovesan P; Fabrizi C; Lauro GM; Campo S; Albertoni C; Nucera E; Carminati P; Ghirardi O
Shock; 2004 Jan; 21(1):77-85. PubMed ID: 14676688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
